Compounds > efavirenz

efavirenz and Kaposi Sarcoma

efavirenz has been researched along with Kaposi Sarcoma in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (40.00)29.6817
2010's2 (40.00)24.3611
2020's1 (20.00)2.80

Authors

AuthorsStudies
Arellano, J; Corredoira, Y; Gonzalez, R; Nuñez, R1
Cardoso, SV; de Faria, PR; Loyola, AM; Servato, JP; Spini, PH; Spini, TH1
Aklillu, E; Bakari, M; Janabi, MY; Lindquist, L; Minzi, OM; Mugusi, FM; Mugusi, SF; Ngaimisi, E; Sandstrom, EG; Sasi, PG1
Campelli, A; Indiveri, F; Murdaca, G; Puppo, F; Setti, M1

Other Studies

5 other study(ies) available for efavirenz and Kaposi Sarcoma

ArticleYear
Diagnosis of elephantiasis nostras verrucosa as a clinical mani-festation of Kaposi's sarcoma.
    Medwave, 2020, Jan-20, Volume: 20, Issue:1

    Topics: AIDS-Related Opportunistic Infections; Alkynes; Anti-HIV Agents; Benzoxazines; Cyclopropanes; Didanosine; Drug Therapy, Combination; Elephantiasis; Humans; Lamivudine; Male; Middle Aged; Sarcoma, Kaposi

2020
Regression of oral Kaposi's sarcoma after combination antiretroviral therapy.
    Infection, 2013, Volume: 41, Issue:6

    Topics: Adenine; Adult; AIDS-Related Opportunistic Infections; Alkynes; Anti-Retroviral Agents; Benzoxazines; Cyclopropanes; Drug Therapy, Combination; Humans; Lamivudine; Male; Organophosphonates; Sarcoma, Kaposi; Tenofovir

2013
Risk factors for mortality among HIV-positive patients with and without active tuberculosis in Dar es Salaam, Tanzania.
    Antiviral therapy, 2012, Volume: 17, Issue:2

    Topics: Adult; AIDS-Related Opportunistic Infections; Alkynes; Antiretroviral Therapy, Highly Active; Benzoxazines; Candidiasis, Oral; CD4 Lymphocyte Count; CD4-Positive T-Lymphocytes; Cohort Studies; Coinfection; Cyclopropanes; Female; HIV Infections; Humans; Karnofsky Performance Status; Leukocyte Count; Male; Middle Aged; Risk Factors; Sarcoma, Kaposi; Tanzania; Tuberculosis

2012
Efavirenz helps get rid of Kaposi's sarcoma (KS).
    TreatmentUpdate, 2002, Volume: 14, Issue:2

    Topics: Acquired Immunodeficiency Syndrome; Adult; Alkynes; Benzoxazines; CD4 Lymphocyte Count; Cyclopropanes; Humans; Male; Oxazines; Reverse Transcriptase Inhibitors; Sarcoma, Kaposi; Viral Load

2002
Complete remission of AIDS/Kaposi's sarcoma after treatment with a combination of two nucleoside reverse transcriptase inhibitors and one non-nucleoside reverse transcriptase inhibitor.
    AIDS (London, England), 2002, Jan-25, Volume: 16, Issue:2

    Topics: Adult; AIDS-Related Opportunistic Infections; Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; CD4 Lymphocyte Count; Cyclopropanes; HIV-1; Homosexuality, Male; Humans; Lamivudine; Male; Nucleosides; Oxazines; Reverse Transcriptase Inhibitors; RNA, Viral; Sarcoma, Kaposi; Treatment Outcome; Viral Load; Zidovudine

2002